
Indoco Remedies Limited has informed the Exchange regarding a press release dated December 06, 2023, titled "Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin Tablets".
Filed with NSE ·

Indoco Remedies Limited has informed the Exchange regarding a press release dated December 06, 2023, titled "Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin Tablets".
6ix hasn’t read this filing yet.
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies